Wednesday, May 31, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Biodetection

Tetracore Completes DHS Validation of Ricin Detector

by Global Biodefense Staff
June 12, 2013

White Powder Biothreat Sample CollectionTetracore Inc. this week announced the successful completion of an extensive study and validation of its BioThreat Alert Lateral Flow Assay (LFA) and BioThreat Alert LFA Reader by the Department of Homeland Security (DHS) for detection of the bioterrorism agent ricin.

Public safety and health concerns lead DHS to perform a comprehensive laboratory validation study of a commercially available LFA for the rapid detection of ricin. When suspect environmental samples, including unknown white powders, are discovered in the field authorities are tasked to determine if ricin or another biological threat agent is present. The goal of this study was to provide a reliable rapid field test for ricin, to enable more informed decision-making by first responders and public health officials. 

The study was coordinated by DHS scientists Dr. David Hodge and Dr. Segaran Pillai with collaborative support from the Centers for Disease Control, Food and Drug Administration, Biological Advanced Research and Development Authority, Federal Bureau of Investigation, Secret Service and the Department of Agriculture.

The detection system was evaluated at five different testing locations, which included state-level public health laboratories in Massachusetts, Texas and Virginia. The study consisted of seven phases to thoroughly test each performance aspect of the LFA, including a repeatability study, an inclusivity panel, an informational panel, a lectin panel, a near-neighbor panel, a white powder panel and testing of BioWatch filter extract. 

This extensive testing and independent validation is unprecedented for commercial lateral flow assays developed for field screening of ricin.

“Tetracore respects our on-going collaboration with DHS and will continue to validate our BioThreat Alert LFA products rigorously, so that public health laboratories and first responders have confidence in screening for biological threats,” stated Dr.Tom O’Brien, Vice President of Tetracore, Inc. 

Source: adapted from PRNewswire, Tetracore

Tags: BioterrorismBioWatchDHSMobile ResponseRicin

Related Posts

Aptitude Awarded Up to $54M BARDA Funding for At-Home Diagnostics
Industry News

Aptitude Awarded Up to $54M BARDA Funding for At-Home Diagnostics

April 20, 2023
small glass vials on an assembly line await filling of vaccine solution
Industry News

Sabin Vaccine Institute to Advance Ebola Sudan and Marburg Vaccines with New BARDA Funding

January 12, 2023
DoD Awards ENA Respiratory $4.38M for Broad-Spectrum Antiviral Development
Industry News

DoD Awards ENA Respiratory $4.38M for Broad-Spectrum Antiviral Development

January 10, 2023
New Material Helps Train First Responders on Biothreats
Biodetection

New Material Helps Train First Responders on Biothreats

January 4, 2023
Load More

Latest News

Vials of finished vaccines

UK Biomanufacturing Fund to Bolster Supply Chain Resilience and Pandemic Preparedness

May 26, 2023
Dr. Sen Pei Discusses Challenges in Forecasting Antimicrobial Resistance

Dr. Sen Pei Discusses Challenges in Forecasting Antimicrobial Resistance

April 26, 2023
Biodefense Headlines – 25 April 2023

Biodefense Headlines – 25 April 2023

April 25, 2023
Aptitude Awarded Up to $54M BARDA Funding for At-Home Diagnostics

Aptitude Awarded Up to $54M BARDA Funding for At-Home Diagnostics

April 20, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2023 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2023 Stemar Media Group LLC